Insider · CIK 0001607643

Gardiner Nathaniel S.

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001607643

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-26	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,187 sh	$8.99	+$46.6K	75,688
2024-02-26	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,187 sh	—	—	77,813
2024-02-12	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−973 sh	$12.41	−$12.1K	70,501
2024-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+3,320 sh	—	—	71,474
2023-12-05	ENTAENANTA PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−2,412 sh	$9.63	−$23.2K	68,154
2023-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−1,595 sh	$9.49	−$15.1K	70,566
2023-11-22	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+83K sh	—	—	83,000
2023-04-18	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,667 sh	$30.00	+$200K	79,980
2023-04-18	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,667 sh	—	—	7,000
2023-02-13	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−6,735 sh	$52.77	−$355K	73,313
2023-02-13	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+9,250 sh	—	—	68,301
2023-02-13	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+11.7K sh	—	—	80,048
2022-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−1,055 sh	$44.33	−$46.8K	59,051
2022-11-23	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+45K sh	—	—	45,000
2022-11-23	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+21K sh	—	—	60,106
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+2,419 sh	—	—	47,196
2022-02-14	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−957 sh	$62.49	−$59.8K	46,239
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+615 sh	—	—	44,777
2021-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−557 sh	$87.68	−$48.8K	59,226
2021-11-19	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+28.4K sh	—	—	28,400
2021-11-19	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+6,800 sh	—	—	59,783
2020-12-15	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−1,540 sh	$42.52	−$65.5K	42,248
2020-12-15	ENTAENANTA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,250 sh	—	—	0
2020-12-15	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,250 sh	—	—	43,788
2020-12-03	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,667 sh	—	—	13,667
2020-12-03	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,667 sh	$30.00	+$50K	38,538
2020-11-20	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+7,600 sh	—	—	36,871
2020-11-20	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+30.8K sh	—	—	30,800
2020-08-05	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,666 sh	$30.00	+$50K	29,271
2020-08-05	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,666 sh	—	—	15,334
2020-03-12	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,000 sh	—	—	17,000
2020-03-12	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,000 sh	$30.00	+$90K	27,605
2020-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+2,475 sh	—	—	25,545
2020-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+412 sh	—	—	23,070
2020-02-12	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−940 sh	$52.76	−$49.6K	24,605
2019-12-16	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−2,331 sh	$63.88	−$149K	22,658
2019-12-16	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,250 sh	—	—	24,989
2019-12-16	ENTAENANTA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,250 sh	—	—	5,250
2019-11-22	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,592 sh	—	—	19,818
2019-11-22	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,592 sh	$31.42	+$50K	19,739
2019-11-18	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+30K sh	—	—	30,000
2019-09-27	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,000 sh	—	—	20,000
2019-09-27	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,000 sh	$30.00	+$150K	19,871
2019-06-26	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,295 sh	$31.42	+$104K	13,147
2019-06-26	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,295 sh	—	—	21,410
2019-06-26	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,295 sh	$31.42	+$104K	14,871
2019-03-06	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,724 sh	—	—	70,976
2019-03-06	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+795 sh	$31.42	+$25K	26,497
2019-03-06	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−795 sh	—	—	24,705
2019-03-06	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,724 sh	$34.70	+$59.8K	25,702

Recent filings

Accepted (ET)
Feb 274
Gardiner Nathaniel S.0001062993-24-004659
SEC(opens sec.gov)
Feb 144
Gardiner Nathaniel S.0001062993-24-003233
SEC(opens sec.gov)
Dec 64
Gardiner Nathaniel S.0001062993-23-022053
SEC(opens sec.gov)
Dec 54
Gardiner Nathaniel S.0001062993-23-021987
SEC(opens sec.gov)
Nov 224
Gardiner Nathaniel S.0001062993-23-021382
SEC(opens sec.gov)
Apr 194
Gardiner Nathaniel S.0001062993-23-009374
SEC(opens sec.gov)
Feb 154
Gardiner Nathaniel S.0001062993-23-003717
SEC(opens sec.gov)
Dec 54
Gardiner Nathaniel S.0001062993-22-023365
SEC(opens sec.gov)
Nov 284
Gardiner Nathaniel S.0001062993-22-022857
SEC(opens sec.gov)
Feb 154
Gardiner Nathaniel S.0001062993-22-004518
SEC(opens sec.gov)
Dec 34
Gardiner Nathaniel S.0001062993-21-012216
SEC(opens sec.gov)
Nov 234
Gardiner Nathaniel S.0001062993-21-011512
SEC(opens sec.gov)

Companies

ENANTA PHARMACEUTICALS INCChief Legal OfficerENTA

Address

C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET

WATERTOWN, MA, 02472